Cognitive
Semax
Decades of use in Russia for focus, mood and stroke recovery, and almost no independent research anywhere else. That gap makes it hard to say with any confidence how well it works or how safe it is outside the country it came from.
Nootropic/neurorehabilitation with limited human literature concentrated in Russian stroke research; modern wellness claims are substantially less established.
How well studied
Tier Guide: A = Well studied, B = Some good studies, C = Early evidence & D = Barely studied
Mostly animal studies or very small early trials in humans. We don't really know yet how it behaves in people.
UK status
How you could legitimately come across it here, if at all
No authorised UK medicine contains this, and we have no record of a routine UK clinic route. Material sold online is unregulated.
Evidence strength and UK regulatory status answer different questions.
Overview
How it works
Thought to support how brain cells grow and connect in areas tied to focus and memory, though the exact process still isn't fully mapped.
A synthetic fragment thought to support neurotrophic signalling pathways linked to focus and mood.
Reported benefits
- Older clinical studies report neurological and rehabilitation outcomes in stroke populations
- Evidence for healthy-person focus, mood or cognitive enhancement is insufficient
Who it's typically used for
Timeline to results
Safety & UK access
Dosage
No established UK/Western clinical dose. Russian clinical protocols exist but haven't been independently validated.
Side effects
- Nasal irritation (intranasal route)reported in the intranasal clinical literature
- Headachereported
- Anxiety or overstimulationreported anecdotally at higher doses; not quantified in trials
Getting it in the UK
No authorised UK medicine contains this, and we have no record of a routine UK clinic route. Material sold online is unregulated.
Where it turns up
- Not routinely available in the UK
- Unregulated online market
No authorised UK medicinal product containing Semax was identified. Russian clinical use or online availability does not imply UK authorisation.
Not MHRA-licensed; not a standard UK private-clinic prescription
MHRA: the UK regulator that assesses whether a medicine is safe and works before it can be authorised for use here. Something not being MHRA-licensed does not automatically mean it is illegal, and it does not mean it is safe.
This is background information about UK regulation, not advice about what you can or should obtain.
Evidence & sources
Why this rating?
The A to D rating shown above comes from our earlier editorial review and is still waiting to be migrated into the structured review record below. That is a gap in our record-keeping, not a sign the rating is wrong.
Evidence fingerprint
No route and indication scope has been published for this profile yet, so no fingerprint is shown.
Sources
Structured source audit not yet published for this profile. The references behind this page are being catalogued one compound at a time, and this one has not been through that process yet.
Content freshness
- Last reviewed
- 24 Sept 2026
- Regulatory status last checked
- 21 Aug 2026